Chang-Hwan Choi - Search Results

Year	Number of Results
2002	1
2003	2
2004	2
2005	3
2006	5
2007	4
2008	5
2009	8
2010	5
2011	12
2012	19
2013	15
2014	10
2015	13
2016	15
2017	16
2018	11
2019	14
2020	15
2021	15
2022	20
2023	18
2024	3

1

Effects of Oxidized Metal Powders on Pore Defects in Powder-Fed Direct Energy Deposition.

Son JY, Lee KY, Lee SH, Choi CH. Son JY, et al. Among authors: choi ch. Micromachines (Basel). 2024 Feb 6;15(2):243. doi: 10.3390/mi15020243. Micromachines (Basel). 2024. PMID: 38398972 Free PMC article.

2

Prediction of Clinical Remission with Adalimumab Therapy in Patients with Ulcerative Colitis by Fourier Transform-Infrared Spectroscopy Coupled with Machine Learning Algorithms.

Kim SY, Shin SY, Saeed M, Ryu JE, Kim JS, Ahn J, Jung Y, Moon JM, Choi CH, Choi HK. Kim SY, et al. Among authors: choi ch. Metabolites. 2023 Dec 19;14(1):2. doi: 10.3390/metabo14010002. Metabolites. 2023. PMID: 38276292 Free PMC article.

3

Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity.

Shin SY, Kim HS, Kim K, Choi CW, Moon JM, Kim JW, Joo HJ, Seo J, Sung M, Choi CH. Shin SY, et al. Among authors: choi ch. Korean J Intern Med. 2024 Jan;39(1):68-76. doi: 10.3904/kjim.2023.167. Epub 2023 Dec 13. Korean J Intern Med. 2024. PMID: 38086619 Free PMC article.

4

Enrichment of Activated Fibroblasts as a Potential Biomarker for a Non-Durable Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohn's Disease.

Park SK, Lee GY, Kim S, Lee CW, Choi CH, Kang SB, Kim TO, Chun J, Cha JM, Im JP, Ahn KS, Kim SY, Kim MS, Lee CK, Park DI. Park SK, et al. Among authors: choi ch. Int J Mol Sci. 2023 Sep 30;24(19):14799. doi: 10.3390/ijms241914799. Int J Mol Sci. 2023. PMID: 37834250 Free PMC article.

5

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.

Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.

6

Regulatory Variants on the Leukocyte Immunoglobulin-Like Receptor Gene Cluster are Associated with Crohn's Disease and Interact with Regulatory Variants for TAP2.

Kim K, Oh SJ, Lee J, Kwon A, Yu CY, Kim S, Choi CH, Kang SB, Kim TO, Park DI, Lee CK. Kim K, et al. Among authors: choi ch. J Crohns Colitis. 2024 Jan 27;18(1):47-53. doi: 10.1093/ecco-jcc/jjad127. J Crohns Colitis. 2024. PMID: 37523193

7

Mechanical and Thermal Properties of the High Thermal Conductivity Steel (HTCS) Additively Manufactured via Powder-Fed Direct Energy Deposition.

Son JY, Lee KY, Shin GY, Choi CH, Shim DS. Son JY, et al. Among authors: choi ch. Micromachines (Basel). 2023 Apr 18;14(4):872. doi: 10.3390/mi14040872. Micromachines (Basel). 2023. PMID: 37421105 Free PMC article.

8

Vaccination in patients with inflammatory bowel disease-Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn's and Colitis meeting.

Park SB, Kim KO, Lee HS, Choi CH, Wei SC, Chen MH, Matsuoka K. Park SB, et al. Among authors: choi ch. Intest Res. 2023 Jul;21(3):363-374. doi: 10.5217/ir.2023.00015. Epub 2023 Jun 16. Intest Res. 2023. PMID: 37322868 Free PMC article.

9

Changes in fecal metabolic and lipidomic features by anti-TNF treatment and prediction of clinical remission in patients with ulcerative colitis.

Kim SY, Shin SY, Park SJ, Im JP, Kim HJ, Lee KM, Kim JW, Jung SA, Lee J, Kang SB, Shin SJ, Kim ES, Kim YS, Kim TO, Kim HS, Park DI, Kim HK, Kim ES, Kim YH, Teng D, Kim JH, Kim W, Saeed M, Moon JM, Kim K, Choi CH, Choi HK. Kim SY, et al. Among authors: choi ch. Therap Adv Gastroenterol. 2023 May 2;16:17562848231168199. doi: 10.1177/17562848231168199. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37153496 Free PMC article.

10

Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn's disease: a KASID prospective multicenter study.

Oh K, Hong HS, Ham NS, Lee J, Park SH, Yang SK, Yoon H, Kim YS, Choi CH, Ye BD; Korean Association for the Study of Intestinal Diseases. Oh K, et al. Among authors: choi ch. Intest Res. 2023 Apr;21(2):273. doi: 10.5217/ir.2021.00173.e. Epub 2023 Apr 28. Intest Res. 2023. PMID: 37139592 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

206 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year